SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia
Blood Adv
.
2022 Jul 12;6(13):3840-3843.
doi: 10.1182/bloodadvances.2022007174.
Authors
Nicholas C J Lee
1
2
,
Bhavisha Patel
3
,
Aaron Etra
4
,
Taha Bat
5
,
Ibrahim F Ibrahim
5
,
Madhuri Vusirikala
5
,
Mingyi Chen
6
,
Flavia Rosado
6
,
Jesse Manuel Jaso
6
,
Neal S Young
3
,
Weina Chen
6
Affiliations
1
Department of Internal Medicine, and.
2
Department of Pediatrics, UT Southwestern Medical Center, Dallas TX.
3
Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD.
4
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY; and.
5
Division of Hematology-Oncology, and.
6
Department of Pathology, UT Southwestern Medical Center, Dallas, TX.
PMID:
35452511
PMCID:
PMC9040401
DOI:
10.1182/bloodadvances.2022007174
No abstract available
MeSH terms
Anemia, Aplastic* / complications
COVID-19* / complications
Humans
Red-Cell Aplasia, Pure* / complications
Red-Cell Aplasia, Pure* / diagnosis
SARS-CoV-2